Statin Use Reduces Cardiac Surgery Complications
|
By HospiMedica International staff writers Posted on 20 Jan 2016 |
|
Statin use both before and after coronary artery bypass grafting (CABG) surgery could reduce complications and risk of death, according to a new study.
Researchers at the Cleveland Clinic (CC; OH, USA) and the University of Florida (UF; Gainesville, USA) conducted a literature review to examine statin use both before and after CABG surgery to evaluate the impact on patient outcomes of continuing or stopping drug use prior to surgery. The researchers reviewed all related articles in the Medline database through July 2015, and weighed the evidence regarding the incidence of statin-related adverse effects in this setting.
The researchers found that statin use prior to CABG surgery may help protect patients from developing atrial fibrillation (AF), a common complication following heart surgery. Preoperative statin therapy was also independently associated with a lower risk of cardiovascular outcomes at 30 days, including death. Taking statins prior to surgery appeared to be well-tolerated by patients, and the risk of side effects was low compared to the potential benefits. The researchers could not define what statin dosage is optimal. The study was published on January 12, 2106, in the Annals of Thoracic Surgery.
“The results of our review call for proactive efforts to counsel patients and surgeons about the benefit of statins, a benefit that definitely outweighs the risk of rare potential side effects,” said lead author Amr Baraka, MD, of the Cleveland Clinic. “Even in patients who were not having heart-based interventions, statins had a positive influence on recovery.”
According to the US Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA), cholesterol-lowering medication is used by 28% of Americans over the age of 40, and statins account for more than 90% of these drugs. But beyond lowering lipid levels, statins also exert a constellation of pleiotropic beneficial effects, which include an anti-inflammatory role. CABG is associated with an intense systemic inflammatory response, which has been linked to postoperative complications.
Related Links:
Cleveland Clinic
University of Florida
US Centers for Disease Control and Prevention
Researchers at the Cleveland Clinic (CC; OH, USA) and the University of Florida (UF; Gainesville, USA) conducted a literature review to examine statin use both before and after CABG surgery to evaluate the impact on patient outcomes of continuing or stopping drug use prior to surgery. The researchers reviewed all related articles in the Medline database through July 2015, and weighed the evidence regarding the incidence of statin-related adverse effects in this setting.
The researchers found that statin use prior to CABG surgery may help protect patients from developing atrial fibrillation (AF), a common complication following heart surgery. Preoperative statin therapy was also independently associated with a lower risk of cardiovascular outcomes at 30 days, including death. Taking statins prior to surgery appeared to be well-tolerated by patients, and the risk of side effects was low compared to the potential benefits. The researchers could not define what statin dosage is optimal. The study was published on January 12, 2106, in the Annals of Thoracic Surgery.
“The results of our review call for proactive efforts to counsel patients and surgeons about the benefit of statins, a benefit that definitely outweighs the risk of rare potential side effects,” said lead author Amr Baraka, MD, of the Cleveland Clinic. “Even in patients who were not having heart-based interventions, statins had a positive influence on recovery.”
According to the US Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA), cholesterol-lowering medication is used by 28% of Americans over the age of 40, and statins account for more than 90% of these drugs. But beyond lowering lipid levels, statins also exert a constellation of pleiotropic beneficial effects, which include an anti-inflammatory role. CABG is associated with an intense systemic inflammatory response, which has been linked to postoperative complications.
Related Links:
Cleveland Clinic
University of Florida
US Centers for Disease Control and Prevention
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Short Phlebotomy Cart
MSWA-3469-WHT
New
VTE Prevention System
Flowtron ACS900
Latest Surgical Techniques News
- Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery
- LED-Based Imaging System Could Transform Cancer Detection in Endoscopy
- New Surgical Microscope Offers Precise 3D Imaging Using 48 Tiny Cameras
- First-Of-Its-Kind Drug Illuminates Nerve Tissue for Faster and Safer Surgery
- Neuroform Atlas Stent-Assisted Coiling Found Effective Even in Smaller Arteries
- New Surgical Technique Safely Removes Giant Nerve Tumors
- Breakthrough Polymer Significantly Improves Safety of Implantable Medical Devices
- First-Ever Technology Makes Blood Translucent During Surgery
- Tibia Nailing System with Novel Side-Specific Nails to Revolutionize Fracture Surgery
- New Imaging Probe to Transform Brain Cancer Surgery
- New Technology More Than Doubles Success Rate for Blood Clot Removal
- Surgical Ablation During CABG Improves Survival in Patients with Preexisting Atrial Fibrillation
- New Battery Technology Delivers Additional Power to Implantable Medical Devices
- New Model Reveals Optimal Positioning of Orthopedic Screws in Fractures
- Non-Invasive Tool for Removing Lung Cancer Tumors Reduces Surgical Trauma
- Advanced Imaging Endoscopes to Revolutionize Detection and Treatment of Gastrointestinal Disorders
Channels
Critical Care
view channel
Implantable Device Could Save Diabetes Patients from Dangerously Low Blood Sugar
For individuals with Type 1 diabetes, hypoglycemia (low blood sugar) presents a life-threatening threat, particularly when glucose levels drop too low, which can result in seizures, coma, or even death.... Read more
New Prostate Screening Device Could Replace Traditional Examination Method
Prostate cancer is a leading health concern, with one in seven men being diagnosed with the disease. Early detection is critical for improving patient outcomes, but traditional diagnostic methods, such... Read more
Patient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read more
Business
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
